Myofascial dysfunction associated with chronic pelvic floor pain: Management strategies

Current Pain and Headache Reports

Volumn 11, Issue 5, 2007, Pages 359-364

  Srinivasan, Arun K ^a   Kaye, Jonathan D ^b   Moldwin, Robert ^b  

^a The Arthur Smith Institute for Urology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANALGESIC AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; BUPIVACAINE; CARISOPRODOL; CHOLINERGIC RECEPTOR; CYCLOBENZAPRINE; DIAZEPAM; METHOCARBAMOL; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PENTOSAN POLYSULFATE; PLACEBO; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; ATAXIA; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DISEASE ASSOCIATION; DROWSINESS; DRUG RECEPTOR BINDING; DYSKINESIA; DYSTONIA; FATIGUE; FEEDBACK SYSTEM; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; INTERSTITIAL CYSTITIS; IRRITABLE COLON; KIDNEY DYSFUNCTION; LIBIDO DISORDER; MANAGED CARE; MASSAGE; MENTAL DISEASE; MYOFASCIAL PAIN; NEUROLOGY; NEUROMODULATION; NEUROMUSCULAR DISEASE; OPIATE ADDICTION; PATHOPHYSIOLOGY; PELVIC DISEASE; PELVIC FLOOR MUSCLE TRAINING; PELVIC ORGAN PROLAPSE; PELVIS PAIN SYNDROME; PHYSICIAN; PHYSIOTHERAPIST; PHYSIOTHERAPY; PROTEIN SYNTHESIS INHIBITION; PSYCHIATRIST; PSYCHOSOCIAL CARE; REVIEW; TACHYCARDIA; TREATMENT PLANNING; TREMOR; TRIGGER POINT; URINE RETENTION; XEROSTOMIA;

ACUPUNCTURE; BIOFEEDBACK (PSYCHOLOGY); BOTULINUM TOXINS; CHRONIC DISEASE; EXERCISE THERAPY; HUMANS; MYOFASCIAL PAIN SYNDROMES; PELVIC FLOOR; PELVIC PAIN;

EID: 34848867490     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-007-0218-0     Document Type: Review

References (32)

1. Sinaki M, Merritt JL, Stilwell GK: Tension myalgia of the pelvic floor. Mayo Clin Proc 1977, 52:717-722.
2. Hetrick DC, Ciol MA, Rothman I, et al.: Musculo-skeletal dysfunction in men with chronic pelvic pain syndrome type III: a case control study. J Urol 2003, 170:828-831.
3. Moldwin RM, Kaye JD: Pelvic floor dysfunction in the painful bladder syndrome/interstitial cystitis population. Paper presented at the 2006 NIDDK International Symposium: Frontiers in Painful Bladder Syndrome and Interstitial Cystitis. Bethesda, MD; October 26-27, 2006.
4. The International Pelvic Pain Society, Research Committee: Pelvic Pain Assessment Form. http://www.pelvicpain.org/pdf/ frm_pain_questionnaire.pdf. Accessed July 30, 2007.
5. Howard FM: Introduction. In Pelvic Pain - Diagnosis and Treatment. Edited by Howard FM, Perry CP, Carter JE, El-Minawi AM. Philadelphia: Lippincott Williams & Wilkins; 2000:477-492.
6. Prior A, Whorwell PJ, Faragher EB: Irritable bowel syndrome in the gynecological clinic. Survey of 798 new referrals. Dig Dis Sci 1989, 34:1820-1824.
7. Parsons CI, Dell J, Stanford EJ, et al.: The prevalence of interstitial cystitis in gynecological patients with chronic pelvic pain, as detected by intravescical potassium sensitivity. Am J Obstet Gynecol 2002, 187:1395-1400.
8. Eisenberg ER, Moldwin RM: Etiology: where does prostatitis stop and interstitial cystitis begin? World J Urol 2003, 21:64-69.
9. Peters AA, Van Dorst E, Jellis B, et al.: A randomized clinical trial to compare two different approaches in women with chronic pelvic pain. Obstet Gynecol 1991, 77:740-744.
10. The Initial Management of Chronic Pelvic Pain. RCOG Guidelines. London: Royal College of Obstetricians and Gynaecologists; 2005.
11. Hetrick DC, Glazer H, Liu YW, et al.: Pelvic floor electromyography in men with chronic pelvic pain syndrome: a case-control study. Neurourol Urodyn 2006, 25:46-49.
12. Clemens JQ, Nadler RB, Schaeffer AJ, et al.: Biofeedback, pelvic floor re-education and bladder training for male chronic pelvic pain syndrome. Urology 2000, 56:951-955.
13. Cornel EB, van Haarst E, Schaarsberg RWMB, et al.: The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Eur Urol 2005, 47:607-611.
14. Lukban JC, Whitmore KF, Kellogg-Spadt S, et al.: The effect of manual physical therapy in patients with interstitial cystitis, high tone pelvic floor dysfunction and sacro-iliac dysfunction. Paper presented at the NIDDK Interstitial Cystitis and Bladder Research Symposium. Minneapolis, MN; October 19-20, 2000.
15. Milburn A, Reiter RC, Rhomberg AT: Multidisciplinary approach to chronic pelvic pain. Obstet Gynecol Clin North Am 1993, 20:643-661.
16. Howard FM: Chronic pain as a diagnosis. In Pelvic Pain-Diagnosis and Treatment. Edited by Howard FM, Perry CP, Carter JE, El-Minawi AM. Philadelphia: Lippincott Williams & Wilkins; 2000:493-500.
17. Zermann DH, Ishigooka M, Doggweiler R, et al.: Neurological insights into the etiology of genitourinary pain in men. J Urol 1999, 161:903-908.
18. Dunlap KT, Yu L, Fisch BJ, et al.: Polysomnographic characteristics of sleep disorders in chronic pelvic pain. Prim Care Update Ob Gyns 1998, 5:195.
19. Sator-Katzenschlager SM, Scharbert G, Kress HG, et al.: Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr 2005, 117:761-768.
20. Howard FM: Abdominal wall and pelvic myofascial trigger points. In Pelvic Pain - Diagnosis and Treatment. Edited by Howard FM, Perry CP, Carter JE, El-Minawi AM. Philadelphia: Lippincott Williams & Wilkins; 2000:314-358.
21. Thiele GH: Coccydynia: cause and treatment. Dis Colon Rectum 1963, 6:422-436.
22. Weiss JM: Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2001, 166:2226-2231.
23. Anderson RU, Wise D, Sawyer T, et al.: Integration of myofascial trigger point release and paradoxical training treatment of chronic pelvic pain in men. J Urol 2005, 174:155-160.
24. Schmidt RA, Jonas U, Oleson KA, et al.: Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol 1999, 162:352.
25. Siegel S, Paszkiewicz E, Kirkpatrick C, et al.: Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol 2001, 166:1742-1745.
26. Aboseif S, Tamaddon K, Chalfin S, et al.: Sacral neuro-modulation as an effective treatment for refractory pelvic floor dysfunction. Urology 2002, 60:52-56.
27. Jarvis S, Abbott J, Lenart M, et al.: Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol 2004, 44:46-50.
28. Abbott 1A, Jarvis SK, Lyons SD, et al.: Botulinum toxin type A for chronic pelvic pain and pelvic floor spasm in women. Obstet Gynecol 2006, 108:915-923.
29. Zermann D, Ishigooka M, Schubert J, et al.: Perisphincteric injection of botulinum toxin type A: a treatment option for patients with chronic prostatic pain? Eur Urol 2000, 38:393-399.
30. Thomson AJM, Jarvis SK, Lenart M, et al.: The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles. BJOG 2005, 112:247-249.
31. Chen R, Nickel JC: Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2003, 61:1156-1159.
32. Capodice JL, Jin Z, Bemis DL, et al.: A pilot study on acupuncture for lower urinary tract symptoms related to chronic prostatitis/chronic pelvic pain. Chin Med 2007, 2:1.